CSC
FOLD

Caldwell Sutter Capital’s Amicus Therapeutics FOLD Stock Holding History

Caldwell Sutter Capital’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.78K Hold
400
– – ﹤0.01% 622
2025
Q4 		$5.7K Hold
400
– – ﹤0.01% 619
2025
Q3 		$3.15K Buy
400
+70
+21% +$498 ﹤0.01% 690
2025
Q2 		$1.89K Hold
330
– – ﹤0.01% 726
2025
Q1 		$2.69K Hold
330
– – ﹤0.01% 697
2024
Q4 		$3.11K Hold
330
– – ﹤0.01% 697
2024
Q3 		$3.52K Hold
330
– – ﹤0.01% 691
2024
Q2 		$3.27K Hold
330
– – ﹤0.01% 692
2024
Q1 		$3.89K Hold
330
– – ﹤0.01% 656
2023
Q4 		$4.68K Hold
330
– – ﹤0.01% 638
2023
Q3 		$4.01K Hold
330
– – ﹤0.01% 634
2023
Q2 		$4.14K Buy
+330
New +$3.92K ﹤0.01% 636

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Caldwell Sutter Capital's FOLD Position: Q1 2026 in Review

Caldwell Sutter Capital held its Amicus Therapeutics (FOLD) position steady in Q1 2026 at 400 shares worth $5.78K. The position accounts for ﹤0.01% of the portfolio, ranked #622.

Caldwell Sutter Capital first reported a position in FOLD in Q2 2023 and has held it in 12 quarters since. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Caldwell Sutter Capital held 400 shares of Amicus Therapeutics worth $5.78K as of Q1 2026.
  • Caldwell Sutter Capital left its Amicus Therapeutics share count unchanged in Q1 2026.
  • Amicus Therapeutics made up ﹤0.01% of Caldwell Sutter Capital's portfolio in Q1 2026, its #622 holding.
  • Caldwell Sutter Capital first reported a position in Amicus Therapeutics in Q2 2023 and has held it in 12 quarters since.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Caldwell Sutter Capital's 13F filing for Q1 2026, filed 6 May 2026.